The stability window runs up to 14 days, but always check the batch COA
CJC-1295 (No DAC)/Ipamorelin Blend 5+5mg Summary Description: The CJC-1295 (no DAC) + Ipamorelin peptide blend merges two potent growth hormone secretagogues to synergistically enhance physiologic GH pulsatility
Consequently, dose titration is slow and dependent on AEs, and common recommendations like reduction on food quantity or high fat or spicy food is always suggested (151, 154, 158) Also, some hypotheses might suggest that GLP-1 stimulation can affect taste perception, as it has been reported by the FDA Adverse Event Reporting System (FAERS)
The once-weekly dosing schedule is designed to achieve steady-state concentrations, and minor delays within five days typically do not significantly disrupt this equilibrium
Rare side effects are hypoglycemia, pancreatitis, diabetic retinopathy, gall bladder problems, gastroparesis (due to slowed gastric emptying), and increased risk of aspiration during sedation and anesthesia
